Impact of Generative AI Technology in Biopharma Industry

The chapter explores how Sanofi is utilizing generative AI in drug discovery and daily operations to enhance efficiency, decision-making, and the search for new medicines. They discuss partnerships with OpenAI and a German startup to customize language models for drug discovery. Additionally, it touches on topics like workforce empowerment, R&D focus, partnerships for data access, and the decision to become a pure play biopharma company.